Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury

NCT ID: NCT07128901

Last Updated: 2025-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare two types of wearable lower-extremity exoskeletons -a self-balancing device lower-extremity exoskeleton and a user-balancing device lower-extremity exoskeleton-to better understand their effects on the physiological responses to walking and the user experience in people with spinal cord injury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although Lower Limb Exoskeleton technology holds promise for improving mobility and independence in people with Spinal Cord Injury, limited research has examined the physiological and psychological effects of walking with self-balancing lower limb exoskeleton technology compared to systems that require user-operated assistive aids. Moreover, no studies to date have directly compared the short- and long-term outcomes of two lower limb exoskeleton technology types: (1) self-balancing and (2) user-balancing. To address this gap, this study will conduct a head-to-head comparison of self-balancing and user-balancing lower limb exoskeleton technology in individuals with motor-complete (ASIA Impairment Scale Classification \[AIS\] A/B) Spinal Cord Injury-a population that remains underrepresented in rehabilitation robotics research despite advances in the field.

Study participants will complete 5 walking sessions and 2 test sessions with two different exoskeleton devices in a randomized order. During each test session, data will be collected using motion sensors, portable metabolic monitors, and muscle sensors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injuries

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

lower limb exoskeleton

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Self-balancing lower limb exoskeleton

Participants will use the self-balancing lower limb exoskeleton for 5 walking sessions and then complete a test session.

Group Type EXPERIMENTAL

Wandercraft Atalante X

Intervention Type DEVICE

Self-balancing lower limb exoskeleton

User-balancing lower limb exoskeleton

Participants will use the user-balancing lower limb exoskeleton for 5 walking sessions and then complete a test session.

Group Type EXPERIMENTAL

Ekso Indego Therapy

Intervention Type DEVICE

User-balancing lower Limb exoskeleton

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ekso Indego Therapy

User-balancing lower Limb exoskeleton

Intervention Type DEVICE

Wandercraft Atalante X

Self-balancing lower limb exoskeleton

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subacute to chronic SCI (≥ 3mths post injury)
* Motor-complete (ASIA Impairment Scale classification A/B)
* Injury level T3-T10
* Age 18-70 yrs
* Height between 5'1" and 6'1"
* Weight \<200 lbs (90kg)
* Seated hip width \< 42cm
* Standing tolerance \> 15mins
* Have sufficient upper limb strength to use a platform rolling walker, rolling walker, or forearm crutches
* Currently medically cleared and enrolled in the Shepherd Center Beyond Therapy program
* Medically cleared for weight-bearing activities
* Able to follow directions to safely participate in assessments

Exclusion Criteria

* Existing skin lesions or wounds
* Hip or knee contracture \> 10 degrees or ankle contracture \> 5 degrees
* Severe or uncontrolled spasticity
* Non-healing fractures
* Uncontrolled autonomic dysreflexia
* Heart or peripheral vascular condition
* Pregnancy
* Active heterotopic ossification
* Active deep vein thrombosis
* Cognitive deficits that make it difficult for participants to follow verbal instructions or making it unsafe to participate in assessments.
* Any reason the principal investigator feels the potential participant may not be safe to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shepherd Center, Atlanta GA

OTHER

Sponsor Role collaborator

Georgia Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maegan Tucker

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Shepherd Center

Atlanta, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maegan Tucker, PhD

Role: CONTACT

Phone: 617-417-4211

Email: [email protected]

Nick Evans, PhD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maegan Tucker, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2331046-1

Identifier Type: -

Identifier Source: org_study_id